Advancements in Radiomics and Artificial Intelligence for Thyroid Cancer Diagnosis

Thyroid cancer is an increasing global health concern that requires advanced diagnostic methods. The application of AI and radiomics to thyroid cancer diagnosis is examined in this review. A review of multiple databases was conducted in compliance with PRISMA guidelines until October 2023. A combination of keywords led to the discovery of an English academic publication on thyroid cancer and related subjects. 267 papers were returned from the original search after 109 duplicates were removed. Relevant studies were selected according to predetermined criteria after 124 articles were eliminated based on an examination of their abstract and title. After the comprehensive analysis, an additional six studies were excluded. Among the 28 included studies, radiomics analysis, which incorporates ultrasound (US) images, demonstrated its effectiveness in diagnosing thyroid cancer. Various results were noted, some of the studies presenting new strategies that outperformed the status quo. The literature has emphasized various challenges faced by AI models, including interpretability issues, dataset constraints, and operator dependence. The synthesized findings of the 28 included studies mentioned the need for standardization efforts and prospective multicenter studies to address these concerns. Furthermore, approaches to overcome these obstacles were identified, such as advances in explainable AI technology and personalized medicine techniques. The review focuses on how AI and radiomics could transform the diagnosis and treatment of thyroid cancer. Despite challenges, future research on multidisciplinary cooperation, clinical applicability validation, and algorithm improvement holds the potential to improve patient outcomes and diagnostic precision in the treatment of thyroid cancer.

Current and future roles of artificial intelligence in retinopathy of prematurity

Retinopathy of prematurity (ROP) is a severe condition affecting premature infants, leading to abnormal retinal blood vessel growth, retinal detachment, and potential blindness. While semi-automated systems have been used in the past to diagnose ROP-related plus disease by quantifying retinal vessel features, traditional machine learning (ML) models face challenges like accuracy and overfitting. Recent advancements in deep learning (DL), especially convolutional neural networks (CNNs), have significantly improved ROP detection and classification. The i-ROP deep learning (i-ROP-DL) system also shows promise in detecting plus disease, offering reliable ROP diagnosis potential. This research comprehensively examines the contemporary progress and challenges associated with using retinal imaging and artificial intelligence (AI) to detect ROP, offering valuable insights that can guide further investigation in this domain. Based on 89 original studies in this field (out of 1487 studies that were comprehensively reviewed), we concluded that traditional methods for ROP diagnosis suffer from subjectivity and manual analysis, leading to inconsistent clinical decisions. AI holds great promise for improving ROP management. This review explores AI's potential in ROP detection, classification, diagnosis, and prognosis.